Barostim neo™

0 reviews

Minneapolis, United States

Barostim neo™ is the second-generation implantable device, from CVRx. In August 2011 they announced the launch of a clinical trial to evaluate Barostim therapy for the treatment of heart failure. The Barostim neo features a unilateral, 1mm electrode and a new smaller, more advanced generator to allow for more focused and efficient delivery of therapy, leading to shorter procedure ti ...
Read More...